← Back to Clinical Trials
Recruiting NCT07170449

NCT07170449 Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07170449
Status Recruiting
Phase —
Sponsor Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Condition Carpal Tunnel Syndrome (CTS)
Study Type OBSERVATIONAL
Enrollment 84 participants
Start Date 2025-08-01
Primary Completion 2026-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Nerve conduction studiesMedian nerve ultrasonographySensory testing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 84 participants in total. It began in 2025-08-01 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study was to investigate the relationship between different ultrasonographic indices used in patients with carpal tunnel syndrome and the level of tactile sensation. The primary questions the study aimed to answer are: • To what extent are the ultrasonographic parameters used in the diagnosis of carpal tunnel syndrome related to the level of sensory complaints in the patient?

Eligibility Criteria

Inclusion Criteria: * Electrodiagnostic diagnosis of carpal tunnel syndrome with pain, numbness, burning, and tingling consistent with the median nerve dermatomal area lasting at least 6 weeks. * Literate * Agree to participate in the study Exclusion Criteria: * Concomitant diabetes, systemic inflammatory disease, active infection, and history of malignancy * Being \<18 and \>65 years old * Being illiterate * Refusing to participate in the study * Having a disease with neuropathic pain, such as polyneuropathy, radiculopathy, or MS * Other concomitant upper extremity entrapment neuropathies (e.g., cubital tunnel syndrome) * Having undergone surgery for carpal tunnel syndrome * Rheumatoid arthritis, advanced hand osteoarthritis

Contact & Investigator

Central Contact

Müyesser Cavlak, PhD

✉ muyessercavlak@hotmail.com

📞 +905426406118

Principal Investigator

Müyesser Cavlak, PhD

PRINCIPAL INVESTIGATOR

Sultan Abdülhamit Han Trainin and Educatioal Hospital

Frequently Asked Questions

Who can join the NCT07170449 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Carpal Tunnel Syndrome (CTS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07170449 currently recruiting?

Yes, NCT07170449 is actively recruiting participants. Contact the research team at muyessercavlak@hotmail.com for enrollment information.

Where is the NCT07170449 trial being conducted?

This trial is being conducted at Üsküdar, Turkey (Türkiye).

Who is sponsoring the NCT07170449 clinical trial?

NCT07170449 is sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. The principal investigator is Müyesser Cavlak, PhD at Sultan Abdülhamit Han Trainin and Educatioal Hospital. The trial plans to enroll 84 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology